Entry requirements | Human Factors & System Safety Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personal

https://www.humanfactors.lth.se/ny-sajt/msc-programme/entry-requirements/ - 2025-04-21

Accessibility statement | Industrial Design Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally iden

https://www.ide.lth.se/accessibility-statement/ - 2025-04-21

Education | Industrial Design Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable infor

https://www.ide.lth.se/education/ - 2025-04-21

Accessibility statement | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally ident

https://www.immun.lth.se/accessibility-statement/ - 2025-04-21

U-READ: Unit for Rapid Engineered Antibody Development | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do

https://www.immun.lth.se/infrastructure/u-read-unit-for-rapid-engineered-antibody-development/ - 2025-04-21

Focus Areas | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable info

https://www.immun.lth.se/research-new/focus-areas/ - 2025-04-21

Biomarker proteomics | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifi

https://www.immun.lth.se/research-new/senior-researchers/fredrik-levander/research/biomarker-proteomics/ - 2025-04-21

Novel immune cell targets for efficient treatment of AML | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies

https://www.immun.lth.se/research-new/senior-researchers/kristina-lundberg/research/novel-immune-cell-targets-for-efficient-treatment-of-aml/ - 2025-04-21

Research | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable informa

https://www.immun.lth.se/research-new/senior-researchers/mats-ohlin/research/ - 2025-04-21

Human IgE repertoires and an anti-allergome resource | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do n

https://www.immun.lth.se/research-new/senior-researchers/mats-ohlin/research/human-ige-repertoires-and-an-anti-allergome-resource/ - 2025-04-21

4BUH - human anti-Bet v 1 IgE | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally

https://www.immun.lth.se/research-new/senior-researchers/mats-ohlin/research/human-ige-repertoires-and-an-anti-allergome-resource/4buh-human-anti-bet-v-1-ige/ - 2025-04-21

Affinity-based analysis of liquid biopsies | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store a

https://www.immun.lth.se/research-new/senior-researchers/sara-ek/research/affinity-based-analysis-of-liquid-biopsies/ - 2025-04-21

Innovations | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable info

https://www.immun.lth.se/research/innovations/ - 2025-04-21

Affinity Proteomics | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifia

https://www.immun.lth.se/research/principal-investigators/carl-borrebaeck/research/affinity-proteomics/ - 2025-04-21

Challenge Driven Innovation project (UDI-Prostata) | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not

https://www.immun.lth.se/research/principal-investigators/carl-borrebaeck/research/challenge-driven-innovation-project-udi-prostata/ - 2025-04-21

Molecular Fingerprint of Psychologic Resilience | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not st

https://www.immun.lth.se/research/principal-investigators/carl-borrebaeck/research/molecular-fingerprint-of-psychologic-resilience/ - 2025-04-21

Kathrin Zeller | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable i

https://www.immun.lth.se/research/principal-investigators/kathrin-zeller/ - 2025-04-21

Adverse immune responses induced by xenobiotic compounds | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies

https://www.immun.lth.se/research/principal-investigators/malin-lindstedt/research/adverse-immune-responses-induced-by-xenobiotic-compounds/ - 2025-04-21

Doctoral theses | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable

https://www.immun.lth.se/research/principal-investigators/mats-ohlin/doctoral-theses/ - 2025-04-21

Cancer | Immunotechnology Skip to main content This site uses cookies to enhance the user experience. By continuing to use the site you agree that cookies are used according to our Cookie Policy (on the website of LTH) . Essential cookies These cookies are necessary for the website to function and cannot be turned off in our systems. These cookies do not store any personally identifiable informati

https://www.immun.lth.se/research/principal-investigators/peter-james/research/cancer/ - 2025-04-21